Medical Director & Board-Certified Dermatologist
Location: Coal Harbour
Language: English
Specialization: Medical & Cosmetic Dermatology, Clinical Trial Research
Dr. Zarbafian is a double board-certified and fellowship-trained dermatologist with advanced expertise in medical, cosmetic, and procedural dermatology. Hailing from Vancouver, 'Dr. Z' enhanced his aesthetic expertise with a transformative year at the acclaimed center Cosmetic Laser Dermatology in San Diego. His expertise in aesthetics spans across neuromodulators, hyaluronic acid injectables, biostimulators, various other injectables, body contouring and tightening, microneedling with radiofrequency, intense pulsed light, and over 50 types of lasers, including both non-ablative and fully ablative laser resurfacing.
Dr. Zarbafian's medical journey took off at the University of British Columbia, where he gained early admission to medical school prior to completing his undergraduate studies. During his residency at UBC, he distinguished himself as Chief Resident and published numerous research articles in top-tier journals. He is particularly passionate about the importance of skin surveillance and the early detection of skin cancers. He continues to contribute to the advancement of dermatological science by imparting his extensive knowledge as a Clinical Instructor at UBC and having served as a Sub-Investigator on over 14 clinical trials.
Rejuvenation Dermatology’s Clinical Trials Department is a national, multi-site research network dedicated to advancing dermatologic care through ethically conducted, regulated clinical research. Integrated within routine clinical practice, the department partners with global pharmaceutical sponsors to evaluate novel therapies and offers early access to innovative treatment options. The team supports industry-sponsored and investigator-initiated trials across a broad range of indications, collaborating closely with sponsors, CROs, investigators, and ethics boards to deliver high-quality data while maintaining a strong commitment to patient safety.
Since its inception, the division has evolved from a single research-focused clinic into a coordinated, multi-province research network. Today, it operates with standardized infrastructure, centralized oversight, and experienced investigators across Canada.
